VLMS Global Healthcare’s Post

It was just a matter of time before the big digital providers disrupt Primary Health and Diagnostic Services. A very interesting article by Sai Balasubramanian, M.D., J.D. Our report on Digital Health Transformation is prescient in many ways https://rb.gy/goxe7l Gerry Bloom Lewis Husain Anabel Marin . There is an increasing need to look at how the private digital health sector is beginning to shape both health systems and markets. Will this make health care access more equitable, and affordable?

📢 Thrilled to share an article I co-authored with Maya Sandalow at the Bipartisan Policy Center, exploring how we can maximize the value of Remote Patient Monitoring (RPM) technologies! To truly unlock RPM's potential, policymakers should▶️ 1️⃣ Direct remote monitoring tools to the patients who need them the most: such as those with severe disease or poor treatment adherence. 2️⃣ Ensure remote monitoring services are well-implemented: e.g., integrating data directly into EHRs with automated alerts for quick provider response. 3️⃣ Reduce barriers to provider adoption of high-value remote monitoring tools, especially in rural America. 4️⃣ Prioritize federal oversight and evidence generation: today we cannot distinguish the types of health data or devices being used for RPM. Check it out: https://lnkd.in/erG6ePVu #HealthcareInnovation #RPM #Digital #HealthTech #PatientCare

Telemedicine offers real advantages to lots of people - especially people in the business world. But knowing when you need in-person care can make a huge difference in health outcomes. Learn more here - https://lnkd.in/eDJdrcTj

Health care, like many industries, has seen remarkable development through the integration and development of tech. #Telehealth is no exception. Policymakers must recognize the immense innovative potential that can be fostered by making telehealth flexibilities permanent. Read more from our most recent blog: https://lnkd.in/eW9PJ3YE

Navigating the post-pandemic landscape of virtual care reveals a significant shift in focus from volume to genuine value. The insights from Anuja Vaidya's recent article highlight that while telehealth gained traction during the pandemic, it still isn't a universal solution for all clinical scenarios. What struck me was the emphasis on data-driven decision-making. It's not enough to assume that patients prefer virtual care; we need deeper analysis to understand where it truly adds value. The fact that many patients still favor in-person visits, especially for critical examinations, reminds us that telehealth shines best in specific use cases, like behavioral health. #Telehealth #HealthcareInnovation #ValueBasedCare

From better care connections to behavioral health breakthroughs, there's more to digital health than you can imagine. We're talking about human-focused solutions that are already making life better for both patients and providers. The future is here, and it's all about digital care. Discover how Amwell is transforming the future of healthcare: https://ow.ly/7iNE50Uwha7. #GapsInCare #Telehealth #HealthcareInnovation

Biotech & smart pharmaceuticals rely on real-world data (RWD) and evidence (RWE) for decentralized clinical trials, efficacy monitoring, post-market safety, and digital patient engagement. 🚧 However, challenges persist in gathering and safeguarding these insights, especially with rural residents and people in need. 📶 Though convenient, the reliance on Bluetooth-enabled patient monitoring devices can create a barrier for users with limited technical experience. Enter 4G- and 5G-enabled mobile technology, prebundled with reliable and secure connectivity. My recent whitepaper emphasizes its role in remote vitals monitoring for decentralized clinical environments. 🌐 Cellular-based solutions offer always-on RWD and RWE, requiring less effort from participants while ensuring end to end authentication, patient data privacy, and cybersecurity. 🔗 Read the full whitepaper for insights on health equity, personalized care, and patient-focused drug development.

In this article with Chief Healthcare Executive, Amwell's Mia Finkelston talks about the opportunities hybrid care allows for and some of the hurdles the industry is facing. Mia covers a range of topics, including her optimism about the enormous potential for telehealth, particularly in managing chronic diseases. Read the full piece here: https://bit.ly/3VeOh3F. #Telehealth #HybridCare #DigitalTools

Virtual health care has rapidly expanded since 2020, but according to Professor Ateev Mehrotra, the adoption of new technologies like telehealth, has come with challenges, including unequal reimbursement, making the shift to new technologies difficult to navigate for many sectors.

🌍🩺 Break down barriers in patient care with our latest must-read #whitepaper! 📄 You'll see how 4G and #5G #connectivity are bridging gaps in #healthcare, especially for rural and underserved populations. 🌐 💡 Learn how to expedite time-to-market, enhance patient experiences and ensure data security. Discover the future of #healthequity and personalized care. 💊 https://lnkd.in/eBiNxxzW